FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113293166> ?p ?o ?g. }

• W2113293166 endingPage "103" @default.
• W2113293166 startingPage "97" @default.
• W2113293166 abstract "The purpose of the trial was to determine the survival and incidence of secondary tumors in children with medulloblastoma receiving radiotherapy plus chemotherapy. Three hundred seventy-nine eligible patients with nondisseminated medulloblastoma between the ages of 3 and 21 years were treated with 2340 cGy of craniospinal and 5580 cGy of posterior fossa irradiation. Patients were randomized between postradiation cisplatin and vincristine plus either CCNU or cyclophosphamide. Survival, pattern of relapse, and occurrence of secondary tumors were assessed. Five- and 10-year event-free survivals were 81 ± 2% and 75.8 ± 2.3%; overall survivals were 87 ± 1.8% and 81.3 ± 2.1%. Event-free survival was not impacted by chemotherapeutic regimen, sex, race, age at diagnosis, or gender. Seven patients had disease relapse beyond 5 years after diagnosis; relapse was local in 4 patients, local plus supratentorial in 2, and supratentorial alone in 1. Fifteen patients experienced secondary tumors as a first event at a median time of 5.8 years after diagnosis (11 >5 y postdiagnosis). All non-CNS solid secondary tumors (4) occurred in regions that had received radiation. Of the 6 high-grade gliomas, 5 occurred >5 years postdiagnosis. The estimated cumulative 10-year incidence rate of secondary malignancies was 4.2% (1.9%–6.5%). Few patients with medulloblastoma will relapse ≥5 years postdiagnosis; relapse will occur predominantly at the primary tumor site. Patients are at risk for development of secondary tumors, many of which are malignant gliomas. This may become an increasing issue as more children survive." @default.
• W2113293166 created "2016-06-24" @default.
• W2113293166 creator A5001092978 @default.
• W2113293166 creator A5008151347 @default.
• W2113293166 creator A5025567999 @default.
• W2113293166 creator A5039864062 @default.
• W2113293166 creator A5074130935 @default.
• W2113293166 date "2012-10-25" @default.
• W2113293166 modified "2023-09-26" @default.
• W2113293166 title "Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961" @default.
• W2113293166 cites W1778834185 @default.
• W2113293166 cites W1963851790 @default.
• W2113293166 cites W1977826988 @default.
• W2113293166 cites W1989254209 @default.
• W2113293166 cites W2005133500 @default.
• W2113293166 cites W2009539412 @default.
• W2113293166 cites W2022621311 @default.
• W2113293166 cites W2044777300 @default.
• W2113293166 cites W2094197345 @default.
• W2113293166 cites W2100140863 @default.
• W2113293166 cites W2111130338 @default.
• W2113293166 cites W2111565239 @default.
• W2113293166 cites W2111783650 @default.
• W2113293166 cites W2111900445 @default.
• W2113293166 cites W2131131349 @default.
• W2113293166 cites W2135126064 @default.
• W2113293166 cites W2144119945 @default.
• W2113293166 cites W2150794759 @default.
• W2113293166 cites W2163101559 @default.
• W2113293166 cites W2320188351 @default.
• W2113293166 doi "https://doi.org/10.1093/neuonc/nos267" @default.
• W2113293166 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3534419" @default.
• W2113293166 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23099653" @default.
• W2113293166 hasPublicationYear "2012" @default.
• W2113293166 type Work @default.
• W2113293166 sameAs 2113293166 @default.
• W2113293166 citedByCount "209" @default.
• W2113293166 countsByYear W21132931662012 @default.
• W2113293166 countsByYear W21132931662013 @default.
• W2113293166 countsByYear W21132931662014 @default.
• W2113293166 countsByYear W21132931662015 @default.
• W2113293166 countsByYear W21132931662016 @default.
• W2113293166 countsByYear W21132931662017 @default.
• W2113293166 countsByYear W21132931662018 @default.
• W2113293166 countsByYear W21132931662019 @default.
• W2113293166 countsByYear W21132931662020 @default.
• W2113293166 countsByYear W21132931662021 @default.
• W2113293166 countsByYear W21132931662022 @default.
• W2113293166 countsByYear W21132931662023 @default.
• W2113293166 crossrefType "journal-article" @default.
• W2113293166 hasAuthorship W2113293166A5001092978 @default.
• W2113293166 hasAuthorship W2113293166A5008151347 @default.
• W2113293166 hasAuthorship W2113293166A5025567999 @default.
• W2113293166 hasAuthorship W2113293166A5039864062 @default.
• W2113293166 hasAuthorship W2113293166A5074130935 @default.
• W2113293166 hasBestOaLocation W21132931661 @default.
• W2113293166 hasConcept C120665830 @default.
• W2113293166 hasConcept C121332964 @default.
• W2113293166 hasConcept C126322002 @default.
• W2113293166 hasConcept C141071460 @default.
• W2113293166 hasConcept C142724271 @default.
• W2113293166 hasConcept C143998085 @default.
• W2113293166 hasConcept C2776694085 @default.
• W2113293166 hasConcept C2776755627 @default.
• W2113293166 hasConcept C2779429289 @default.
• W2113293166 hasConcept C2780789225 @default.
• W2113293166 hasConcept C2781413609 @default.
• W2113293166 hasConcept C2911091166 @default.
• W2113293166 hasConcept C509974204 @default.
• W2113293166 hasConcept C61511704 @default.
• W2113293166 hasConcept C71924100 @default.
• W2113293166 hasConcept C88879693 @default.
• W2113293166 hasConceptScore W2113293166C120665830 @default.
• W2113293166 hasConceptScore W2113293166C121332964 @default.
• W2113293166 hasConceptScore W2113293166C126322002 @default.
• W2113293166 hasConceptScore W2113293166C141071460 @default.
• W2113293166 hasConceptScore W2113293166C142724271 @default.
• W2113293166 hasConceptScore W2113293166C143998085 @default.
• W2113293166 hasConceptScore W2113293166C2776694085 @default.
• W2113293166 hasConceptScore W2113293166C2776755627 @default.
• W2113293166 hasConceptScore W2113293166C2779429289 @default.
• W2113293166 hasConceptScore W2113293166C2780789225 @default.
• W2113293166 hasConceptScore W2113293166C2781413609 @default.
• W2113293166 hasConceptScore W2113293166C2911091166 @default.
• W2113293166 hasConceptScore W2113293166C509974204 @default.
• W2113293166 hasConceptScore W2113293166C61511704 @default.
• W2113293166 hasConceptScore W2113293166C71924100 @default.
• W2113293166 hasConceptScore W2113293166C88879693 @default.
• W2113293166 hasIssue "1" @default.
• W2113293166 hasLocation W21132931661 @default.
• W2113293166 hasLocation W21132931662 @default.
• W2113293166 hasLocation W21132931663 @default.
• W2113293166 hasLocation W21132931664 @default.
• W2113293166 hasOpenAccess W2113293166 @default.
• W2113293166 hasPrimaryLocation W21132931661 @default.
• W2113293166 hasRelatedWork W1499275448 @default.
• W2113293166 hasRelatedWork W1887460624 @default.
• W2113293166 hasRelatedWork W1994819987 @default.

• next